NV MEDTECH, Inc. — SEC Form D Filing

NV MEDTECH, Inc. filed an SEC Form D on June 5, 2026, reporting $20.89M raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
June 5, 2026
Amount reported
$20.89M
Round stage
Pre-Seed
Industry
Medical Devices
Website
https://www.nvmedtech.net/

What the company does

Securities: Equity, Debt. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Brain aneurysms affect approximately 1 in 50 people, potentially leading to fatal strokes, with a high mortality rate for ruptures.

Solution

NV MEDTECH, Inc. is developing the TUBE flow diverter membrane, which occludes aneurysms and supports tissue growth to facilitate healing, offering potential advantages over previous flow diverters.

Why now

With rising incidences of brain aneurysms and the need for safer, less invasive treatment options, the demand for innovative medical technologies like the TUBE flow diverter is critical.

Verdict

Investors said yes at this moment due to the clear market need for less invasive treatment options for brain aneurysms, betting on the potential efficacy of the TUBE flow diverter over existing solutions. This cleared because the narrative highlighted a critical health issue with an innovative response, not because it showcased established market traction or competitive advantages. However, limited upside exists given the entrenched competition from established medical device players, whose products dominate this space and may overshadow new entrants.

Source: SEC EDGAR Form D filing